A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer

Conclusions: Multivariate panels of serum biomarkers identified in this study demonstrated clinically meaningful improvement over the performance of phi, and warrant further clinical validation, which may contribute to the management of PCa.

Source: Theranostics - April 19, 2021 Category: Molecular Biology Authors: Jin Song, Shiyong Ma, Lori J. Sokoll, Rodrigo V. Eguez, Naseruddin H ö ti, Hui Zhang, Phaedre Mohr, Renu Dua, Dattatraya Patil, Kristen Douglas May, Sierra Williams, Rebecca Arnold, Martin G. Sanda, Daniel W. Chan, Zhen Zhang Tags: Research Paper Source Type: research